Knockout Tested Mouse Monoclonal p27 KIP 1 antibody. Suitable for IHC-P, ICC, IP, Flow Cyt, WB, ICC/IF, IHC-Fr and reacts with Human, Mouse, Rat, Monkey samples. Cited in 22 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human CDKN1B.
View Alternative Names
KIP1, p27, CDKN1B, Cyclin-dependent kinase inhibitor 1B, Cyclin-dependent kinase inhibitor p27, p27Kip1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p27 KIP 1 antibody [SX53G8] (AB193379)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human colon tissue labeling p27 KIP 1 with ab193379 at 1 μg/mL.
- ICC
Unknown
Immunocytochemistry - Anti-p27 KIP 1 antibody [SX53G8] (AB193379)
Immunocytochemical analysis of PFA-fixed MCF-7 cells labeling p27 KIP 1 with ab193379 at 1 μg/mL. A Goat anti-mouse IgG CF488 antibody (Green) was used as a secondary antibody. The membrane is stained with Phalloidin-CF640
- WB
Lab
Western blot - Anti-p27 KIP 1 antibody [SX53G8] (AB193379)
Western blot : Anti-CDKN1B antibody [SX53G8] (ab193379) staining at 1 ug/ml, shown in green; Rabbit anti-alpha Tubulin antibody [EP1332Y] (ab52866) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab193379 was shown to bind specifically to CDKN1B. A band was observed at 30 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in CDKN1B knockout cell line. To generate this image, wild-type and CDKN1B knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-p27 KIP 1 antibody [SX53G8] (ab193379) at 1 µg/mL
Lane 1:
Wild-type HCT 116 cell lysate at 20 µg
Lane 2:
CDKN1B knockout HCT 116 cell lysate at 20 µg
Lane 3:
Wild-type HAP1 cell lysate at 20 µg
Lane 4:
CDKN1B knockout HAP1 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution
Observed band size: 30 kDa
false
- WB
Lab
Western blot - Anti-p27 KIP 1 antibody [SX53G8] (AB193379)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : CDKN1B knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lane 4 : MCF7 whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab193379 observed at 30 kDa. Red - loading control, ab181602, observed at 37 kDa.
ab193379 was shown to specifically recognize CDKN1B in wild-type HAP1 cells as well as additional cross-reactive bands. No bands were observed when CDKN1B knockout samples were used. Wild-type and CDKN1B knockout samples were subjected to SDS-PAGE. ab193379 and ab181602 (Rabbit anti GAPDH loading control) were incubated overnight at 4°C at 1 μg/mL and 1/10,000 dilution respectively. Blots were developed with 800CW Goat anti Rabbit and 680CW Goat anti Mouse secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-p27 KIP 1 antibody [SX53G8] (ab193379)
Predicted band size: 22 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of p27 KIP1 involves its role in controlling cell growth and division. It achieves this by becoming a part of larger protein complexes involving CDKs and cyclins. By directly interacting with these complexes p27 KIP1 modulates cell cycle progression therefore acting as a brake on cellular proliferation. The protein is important in maintaining proper cell cycle checkpoints and preventing uncontrolled cell growth which is essential for normal cellular functioning.
Pathways
The involvement of p27 KIP1 centers on cell cycle regulation and signaling pathways such as the PI3K/AKT pathway. Its interaction with CDKs and cyclins situates it within the core mechanisms that determine cell division timing. p27 KIP1 operates alongside other proteins like cyclin D and CDK4/6 fitting into the regulatory intricacies of these pathways. Proper functioning of these pathways ensures cellular homeostasis and prevents the development of oncogenic processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
Cytotechnology 76:217-229 PubMed38495297
2024
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 6: PubMed37197981
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American Society of Gene Therapy 31:847-865 PubMed36639869
2023
Applications
Unspecified application
Species
Unspecified reactive species
Technology in cancer research & treatment 21:15330338221119745 PubMed35971329
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:314 PubMed35393397
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 27:122-132 PubMed34976432
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 12:1039 PubMed34725331
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:8890-8903 PubMed34382342
2021
Applications
Unspecified application
Species
Unspecified reactive species
The journal of international advanced otology 17:306-312 PubMed34309550
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 12:275 PubMed33723215
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com